Ets-1 proto-oncogene as a potential predictor for poor prognosis of lung adenocarcinoma

Tohoku Journal of Experimental Medicine

Volumn 213, Issue 1, 2007, Pages 41-50

  Yamaguchi, Eiichiro ^a   Nakayama, Toshiyuki ^a   Nanashima, Atsushi ^a   Matsumoto, Keitaro ^a   Yasutake, Toru ^a   Sekine, Ichiro ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Ets 1; Histologic differentiation; Non small cell lung cancer; Prognosis; Subtype

Indexed keywords

PARAFFIN; TRANSCRIPTION FACTOR ETS 1;

ACINAR CELL CARCINOMA; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; PROTO-ONCOGENE PROTEIN C-ETS-1; SURVIVAL ANALYSIS; SURVIVORS;

EID: 34948829690     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.213.41     Document Type: Article

References (43)

1. Alipov, G., Nakayama, T., Ito, M., Kawai, K., Naito, S., Nakashima, M., Niino, D. & Sekine, I. (2005) Overexpression of Ets-1 protooncogene in latent and clinical prostatic carcinomas. Histopathology, 46, 202-208.
2. Bolon, I., Gouyer, V., Devouassoux, M., Vandenbunder, B., Brambillia, C. & Brambilla, E. (1995) Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinoma. Am. J. Pathol., 147, 1298-1310.
3. Bosselut, R., Duvall, J.F, Gegonne, A., Bailly, M., Hemar, A., Brady, J. & Ghysdael, J. (1990) The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus, HTLV-1. EMBO J., 9, 3137-3144.
4. Buggy, Y, Maquire, T.M., McGreal, G., McDermott, E., Hill, A.D., O'Higgins, N. & Duffy, M.J. (2004) Overexpression of the Ets-1 transcription factor in human breast cancer. Br. J. Cancer, 91, 1308-1315.
5. Davidson, B., Risberg, B., Goldberg, I., Nesland, J.M., Berner, A., Trope, C.G., Kristensen, G.B., Bryne, M. & Reich, R. (2001) Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome. Am. J. Surg. Pathol., 25, 1493-1500.
6. Desbiensm, X., Queva, C., Jaffredo, T., Stehelin, D. & Vandenbunder, B. (1991) The relationship between cell proliferation and the transcription of the nuclear oncogenes c-cyc, c-myb and c-ets-1 during feather morphogenesis in the chick embryo. Development, 111, 699-713.
7. Endo, K., Shirai, A., Furukawa, M. & Yoshizaki, T. (2006) Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma. Hum. Pathol., 37, 1111-1116.
8. Higasino, F., Yoshida, K., Noumi, T., Seiki, M. & Fujinaga, K. (1995) Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promotors. Oncogene, 10, 1461-1463.
9. Ho, I.C., Bhat, N.K., Gottschalk, L.R., Lindsten, T., Thompson, C.B., Papas, T.S. & Leiden, J.M. (1990) Sequence-specific binding of human Ets-1 to the T cell receptor alpha gene enhancer. Science, 250, 814-818.
10. Hultgådh-Nilsson, A., Cercek, B., Wang, J.W., Naito, S., Lövdahl, C., Sharifi, B., Forrester, J.S. & Fagin, J.A. (1996) Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro. Circ. Res., 78, 589-595.
11. Ito, T., Nakayama, T., Ito, M., Naito, S., Kanematsu, T. & Sekine, I. (1998) Expression of the ets-1Proto-oncogene in human pancreatic carcinoma. Mod. Pathol., 11, 209-215.
12. Japan Lung Cancer Society (2003) General Rule for Clinical and Pathological Record of Lung Carcinoma. 6th ed., Kanehara, Tokyo, pp. 40-99.
13. Katayama, S., Nakayama, T., Ito, M., Naito, S. & Sekine, I. (2005) Expression of the ets-1 proto-oncogene in human breast carcinoma: differential expression with histological grading and growth pattern. Histol. Histopathol., 20, 119-126.
14. Kaya, M., Yoshida, K., Higasino, F., Mitaka, T., Ishii, S. & Fujinaga, K. (1996) A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene, 12, 221-227.
15. Keehn, C.A., Smoller, B.R. & Morgan, M.B. (2004) Ets-1 immunohistochemical expression in non-melanoma skin carcinoma. J. Cutan. Pathol., 31, 8-13.
16. Kiozumi, S., Fisher, R.J., Fujiwara, S., Jorcyk, C., Bhat, N.K., Seth, A. & Papas, T.S. (1990) Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. Oncogene, 5, 675-681.
17. Kola, I., Brookes, S., Green, A.R., Garber, R., Tymms, M., Pagas, T.S. & Seth, A. (1993) The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc. Nutt. Acad. Sci. USA, 90, 7588-7592.
18. Leprince, D., Gegonne, A., Coll, J., de Taisne, C., Schneeberger, A., Lagrou, C. & Stehelin, D. (1983) A putative second cell-derived oncogene of the avian leukemia retrovirus E26. Nature, 306, 395-397.
19. Lewin, B. (1991) Oncogenic conversion by regulatory changes in transcription factors. Cell, 64, 303-312.
20. Nakayama, T., Ito, M., Ohtsuru, A., Naito, S., Nakashima, M., Fagin, J.A., Yamashita, S. & Sekine, I. (1996) Expression of Ets-1 Proto-oncogene in human gastric carcinoma. Am. J. Pathol., 149, 1931-1939.
21. Nerlov, C., Rorth, P., Blasi, F. & Johnson, M. (1991) Essential AP-1 and PEA3 binding elements in the human urokinase-enhancer display cell type-specific activity. Oncogene, 6, 1583-1592.
22. Nerlov, C., De Cesare, D., Pergola, F., Caracciolo, A., Blasi, F., Jhonsen, M. & Verde, P. (1992) A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site- is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. EMBO J., 11, 4573-4582.
23. Ozaki, I., Mizuta, T., Zhao, G., Yotsumoto, H., Hara, T., Kajihara, S., Hisatomi, A., Sakai, T. & Yamamoto, K. (2000) Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Cancer Res., 60, 6519-6525.
24. Pognonec, P., Boulukos, K.E. & Ghysdael, J. (1999) The c-ets-1 protein is chromatin associated and binds to DNA in vitro. Oncogene, 4, 691-697.
25. Rasio, D., Negrini, M., Manenti, G., Dragani, T.A. & Croce, C.M. (1995) Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: Identification of three independent regions. Cancer Res., 55, 3988-3991.
26. Romano-Spica, V. (1995) Role of ETS1 in IL-2 gene expression. J. Immunol., 1554, 2724-2732.
27. Rosen, G.D., Barks, J.L., Iademarco, M.F., Fisher, R.J. & Dean, D.C. (1994) An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4-integrin gene promoter. J. Biol. Chem., 269, 15652-15660.
28. Saeki, H., Kuwano, H., Kawaguchi, H., Ohno, S. & Sugimachi, K. (2000) Expression of ets-1 transcription factor is correlated with penetrating tumor progression in patients with squamous cell carcinoma of the esophagus. Cancer, 89, 1670-1676.
29. Sasaki, H., Yukiue, H., Moriyama, S., Kobayashi, Y., Nakashima, Y., Kaji, M., Kiriyama, M., Fukai, I., Yamakawa, Y. & Fujii, Y. (2001) Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J. Surg. Res., 101, 242-247.
30. Suzuki, H., Romano-Spica, V., Papas, T.S. & Bhat, N.K. (1995) ETS1 suppresses tumorigenicity of human colon cancer cells. Proc. Natl. Acad. Sci. USA., 92, 4442-4446.
31. Takanami, I., Takeuchi, K. & Karuke, M. (2001) Expression of Ets-1 is correlated with urokinase-type plasminogen activator and poor prognosis in pulmonary adenocarcinoma. Tumor. Biol., 22, 205-210.
32. Takise, A., Kodama, T., Shimosato, Y, Watanabe, S. & Suemasu, K. (1998) Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter. Cancer, 61, 2083-2088.
33. Thomas, R.S., Tymms, M.J., Seth, A., Shannon, M.R & Kola, I. (1995) ETS1 transactivates the human GM-CSF promotor in Jurkat T cells stimulated with PMA and ionomycin. Oncogene, 10, 2135-2143.
34. Vandenbunder, B., Pardanaud, L., Jaffredo, T., Mirabel, M.A. & Stehelin, D. (1989) Complementary patterns of expression of c-ets 1, c-myc in the blood-forming system of the chick embryo. Development, 106, 265-274.
35. Venanzoni, C. (1996) ETS-1 and ETS-2 in p53 regulation: spatial. separation of ETS binding sites (EBS) modulate protein; DNA interaction. Oncogene, 6, 1199-1204.
36. Watson, D.K., McWilliams, M.J., Lapis, R, Lautenberger, J.A., Schweinfest, C.W. & Papas, T.S. (1988) Mammalian ets-1 and ets-2 genes encode highly conserved proteins. Proc. Natl. Acad. Sci. USA, 85, 7862-7866.
37. Wasylyk, C. & Wasylyk, B. (1992) Oncogenic conversion alters the transcriptional properties of ets. Cell Growth Differ., 3, 617-625.
38. Watson, D.K., Ascione, R. & Papas, T.S. (1990) Molecular analysis of the ets genes and their products. Crit. Rev. Oncog., 1, 409-436.
39. Wernert, N., Gilles, F., Fafeur, V., Bouali, F., Raes, M.B., Pyke, C., Dupressoir, T., Seitz, G., Vandenbunder, B. & Stehelin, D. (1994) Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res., 54, 5683-5688.
40. Wilson, L.A., Yamamoto, H. & Singh, G. (2004) Role of the transcription factor Ets-1 in cisplatin resistance. Mol. Cancer Ther., 3, 823-832.
41. World Health Organization (2004) Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC press, Lyon, pp. 10-11.
42. Yang, B.S. (1996) Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets-1 and c-Ets-2. Mol. Cell. Biol., 16, 538-547.
43. Yu, Y., Zhang, Y.C., Zhang, W.Z., Shen, L.S., Hertzog, P., Wilson, T.J. & Xu, D.K. (2003) Ets1 as a marker of malignant potential in gastric carcinoma. World J. Gastroenterol., 9, 2154-2159.